Ulrich Wandschneider

Ulrich Wandschneider currently works at Broermann Holding GmbH, as Chairman-Supervisory Board from 2011, BioNTech SE, as Vice Chairman-Supervisory Board from 2018, Vanguard AG, as Member-Supervisory Board from 2009, Hanns Martin Schleyer-Stiftung, as Trustee, and Marienhaus gGmbH, as Member-Supervisory Board.
Dr. Wandschneider also formerly worked at MediClin AG, as Chairman-Supervisory Board from 2012 to 2019, MPH Health Care AG, as Deputy Chairman-Supervisory Board, Asklepios Kliniken Verwaltungs GmbH, as Chairman-Supervisory Board, Asklepios Kliniken GmbH & Co. KGaA, as Chairman-Supervisory Board from 2011 to 2018, MediClin Müritz-Klinikum GmbH & Co. KG, as Managing Director from 2010 to 2012, Kraichgau-Klinik AG, as Managing Director, MediClin Geschäftsführungs GmbH, as Managing Director, MediClin Medizinisches Versorgungszentrum GmbH, as Managing Director, MVZ MediClin Bonn GmbH, as Managing Director from 2009 to 2012, Yvonne Mobilien Leasing GmbH, as Managing Director, MVZ-Müritz GmbH, as Managing Director from 2010 to 2012, beebusy capital GmbH, as Managing Director in 2021, Asklepios Kliniken Hamburg GmbH, as Member-Supervisory Board, Arthur Andersen & Co. GmbH, as Principal, Asklepios Westklinikum Hamburg GmbH, as Member-Supervisory Board, Deloitte Consulting GmbH, as Partner from 2002 to 2004, Bundesverband Deutscher Privatkliniken eV, as Vice President from 2013 to 2016, and Trilantic Capital Partners LLP, as Operating Partner.
Dr. Wandschneider received his undergraduate degree from the University of Hamburg and undergraduate degree from the University of Zurich.